ARTHQ (Arch Therapeutics) Cyclically Adjusted Book per Share: $-1.78 (As of Jun. 2024)


ARTHQ Arch Therapeutics Inc ARTHQ
12 GF Score
Price $0.00
View Full Analysis

What is Arch Therapeutics Cyclically Adjusted Book per Share?

Arch Therapeutics ARTHQ -99.00% 12 Cyclically Adjusted Book per Share is $-1.78 as of Jun. 2024. GuruFocus rates ARTHQ with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Arch Therapeutics's adjusted book value per share for the three months ended in Jun. 2024 was $-2.827. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-1.78 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-02), Arch Therapeutics's current stock price is $0.0001. Arch Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was $-1.78. Arch Therapeutics's Cyclically Adjusted PB Ratio of today is .


Arch Therapeutics  (OTCPK:ARTHQ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Arch Therapeutics Cyclically Adjusted Book per Share Related Terms


Arch Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Arch Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Therapeutics Cyclically Adjusted Book per Share Chart

Arch Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -2.37 -2.53 -3.10

Arch Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.01 -3.10 -3.08 -2.42 -1.78

ARTHQ vs GRTSQ, MTEM, PXMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Arch Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arch Therapeutics's Cyclically Adjusted PB Ratio falls into.


ARTHQ
12GF Score
Arch Therapeutics Inc ARTHQ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arch Therapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book= Book Value per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-2.827/314.1750*314.1750
=-2.827

Current CPI (Jun. 2024) = 314.1750.

Arch Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201409 -19.144 238.031 -25.268
201412 -14.279 234.812 -19.105
201503 -15.603 236.119 -20.761
201506 -13.071 238.638 -17.208
201509 2.862 237.945 3.779
201512 1.667 236.525 2.214
201603 0.214 238.132 0.282
201606 5.932 241.018 7.733
201609 4.628 241.428 6.023
201612 3.606 241.432 4.692
201703 6.077 243.801 7.831
201706 4.488 244.955 5.756
201709 2.900 246.819 3.691
201712 4.044 246.524 5.154
201803 2.695 249.554 3.393
201806 2.923 251.989 3.644
201809 1.655 252.439 2.060
201812 -0.805 251.233 -1.007
201903 -0.244 254.202 -0.302
201906 -0.198 256.143 -0.243
201909 -0.930 256.759 -1.138
201912 -0.108 256.974 -0.132
202003 -0.571 258.115 -0.695
202006 -0.330 257.797 -0.402
202009 -1.554 260.280 -1.876
202012 -2.662 260.474 -3.211
202103 1.733 264.877 2.056
202106 0.520 271.696 0.601
202109 -0.867 274.310 -0.993
202112 -2.046 278.802 -2.306
202203 -2.581 287.504 -2.820
202206 -3.388 296.311 -3.592
202209 -3.354 296.808 -3.550
202212 -4.715 296.797 -4.991
202303 -5.009 301.836 -5.214
202306 -6.237 305.109 -6.422
202309 -1.601 307.789 -1.634
202312 -2.019 306.746 -2.068
202403 -2.448 312.332 -2.462
202406 -2.827 314.175 -2.827

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-1.78 mean?
Arch Therapeutics (ARTHQ) has a Cyclically Adjusted Book per Share of $-1.78 as of Jun. 2024. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arch Therapeutics and its competitors.
Is Arch Therapeutics' Cyclically Adjusted Book per Share too high?
Arch Therapeutics' current Cyclically Adjusted Book per Share is $-1.78. Overall, Arch Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Arch Therapeutics' Cyclically Adjusted Book per Share compare to GRTSQ and MTEM?
Arch Therapeutics' Cyclically Adjusted Book per Share of $-1.78 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arch Therapeutics and its competitors. Arch Therapeutics's current Cyclically Adjusted Book per Share is $-1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Therapeutics stock overvalued right now?
Arch Therapeutics (ARTHQ) has a current Cyclically Adjusted Book per Share of $-1.78. The current Cyclically Adjusted Book per Share is $-1.78. Arch Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Arch Therapeutics (ARTHQ), the current Cyclically Adjusted Book per Share is $-1.78 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Therapeutics Business Description

Address 235 Walnut Street, Suite 6, Framingham, MA, USA, 01702
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.
12GF Score

Get the complete analysis for ARTHQ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price